MoFo, HSF star in $512 mln Fosun Pharma IPO
BY Kanishk Verghese |
Morrison Foerster has represented Shanghai Fosun Pharmaceutical Group, a Chinese healthcare company, in its HK$3.97 billion ($512 million) initial public offering on the Hong Kong Stock Exchange, the third largest Hong Kong IPO this year.